Cortexyme is a startup based in the United States, 1 tracked investor.
Cortexyme is a startup based in the United States. Brouky records 1 investor associated with the company.
Cortexyme is a clinical-stage pharmaceutical company developing oral therapeutics to treat Alzheimer's disease and other degenerative diseases by targeting bacterial proteases implicated in disease progression.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.